Kezar Life Sciences Inc (KZR)
0.823
-0.02
(-2.02%)
USD |
NASDAQ |
May 08, 16:00
0.823
0.00 (0.00%)
After-Hours: 20:00
Kezar Life Sciences Cash from Operations (Quarterly): -18.98M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -18.98M |
| September 30, 2023 | -20.20M |
| June 30, 2023 | -21.60M |
| March 31, 2023 | -20.86M |
| December 31, 2022 | -15.88M |
| September 30, 2022 | -16.36M |
| June 30, 2022 | -13.29M |
| March 31, 2022 | -13.31M |
| December 31, 2021 | -11.08M |
| September 30, 2021 | -9.954M |
| June 30, 2021 | -13.04M |
| March 31, 2021 | -8.357M |
| December 31, 2020 | -9.307M |
| September 30, 2020 | -9.25M |
| Date | Value |
|---|---|
| June 30, 2020 | -10.09M |
| March 31, 2020 | -8.301M |
| December 31, 2019 | -7.21M |
| September 30, 2019 | -8.255M |
| June 30, 2019 | -7.712M |
| March 31, 2019 | -6.70M |
| December 31, 2018 | -5.473M |
| September 30, 2018 | -4.604M |
| June 30, 2018 | -6.949M |
| March 31, 2018 | -3.766M |
| December 31, 2017 | -1.616M |
| September 30, 2017 | -2.178M |
| June 30, 2017 | -2.303M |
| March 31, 2017 | -2.012M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-21.60M
Minimum
Jun 2023
-7.21M
Maximum
Dec 2019
-12.79M
Average
-11.08M
Median
Dec 2021
Cash from Operations (Quarterly) Benchmarks
| Accuray Inc | -5.093M |
| Tonix Pharmaceuticals Holding Corp | -22.34M |
| Acumen Pharmaceuticals Inc | -8.314M |
| NovaBay Pharmaceuticals Inc | -0.314M |
| Palatin Technologies Inc | -10.48M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 27.88M |
| Cash from Financing (Quarterly) | 0.059M |
| Free Cash Flow | -83.46M |
| Free Cash Flow Per Share (Quarterly) | -0.2609 |
| Free Cash Flow Yield | -139.8% |